Citation Impact
Citing Papers
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
2010 StandoutScience
Resetting the Circadian Clock by Social Experience in Drosophila melanogaster
2002 StandoutScienceNobel
Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain
2004
Trial of Psilocybin versus Escitalopram for Depression
2021 Standout
Non‐Alzheimer‐type pattern of brain cholineacetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy
1989
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
Physical Aggression Is Associated With Preservation of Substantia Nigra Pars Compacta in Alzheimer Disease
1996
Mild Cognitive Impairment: Potential Pharmacological Treatment Options
2000
The elusive transporters with a high affinity for glutamate
1993
Adverse psychological impact, glutamatergic dysfunction, and risk factors for Alzheimer's disease
1998
Memantine in Moderate-to-Severe Alzheimer's Disease
2003 Standout
Neurotransmitter Transporters: Molecular Biology, Function, and Regulation
1995
The cholinergic hypothesis of Alzheimer's disease: a review of progress
1999 Standout
Untargeted Metabolomic Analysis of Human Plasma Indicates Differentially Affected Polyamine and L-Arginine Metabolism in Mild Cognitive Impairment Subjects Converting to Alzheimer’s Disease
2015
The Cholinergic Hypothesis of Neuropsychiatric Symptoms in Alzheimer's Disease
1998
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Glutamate uptake
2001 Standout
Mild Cognitive Impairment
1999 Standout
Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment
2002 Standout
Regional changes in [3H]d-aspartate and [3H]TCP binding sites in Alzheimer's disease brains
1988
Excitatory amino acids and neuropsychiatrie disorders
1989
Altered expression of glutamate transporter GLAST mRNA in rat brain after photochemically induced focal ischemia
1998
Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice
1995 StandoutNatureNobel
Mild Cognitive Impairment
2011 Standout
Cloning and expression of a glutamate transporter from mouse brain
1993
The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment
2005 Standout
Psychedelics
2016 Standout
Dopamine Receptor Genetic Variation, Psychosis, and Aggression in Alzheimer Disease
1998
Amyotrophic lateral sclerosis
2011 Standout
L-TRANs-Pyrrolidine-2,4-dicarboxylate and cis-1-aminocyclobutane-1, 3-dicarboxylate behave as transportable, competitive inhibitors of the high-affinity glutamate transporters
1994
Quantitative Cerebral Anatomy in Depression
1993
Global prevalence of dementia: a Delphi consensus study
2005 Standout
Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders
2001
Neuropathological stageing of Alzheimer-related changes
1991 Standout
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
2005 StandoutNature
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
2012 Standout
Sodium dependent d-[3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases
1987
A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds
1993 StandoutNature
Neuroprotective and symptomatological action of memantine relevant for alzheimer’s disease — a unified glutamatergic hypothesis on the mechanism of action
2000
Molecular cloning of two glutamate transporter subtypes from mouse brain
1995
GABAAreceptors in aging and Alzheimer’s disease
2007
Expression of betaine transporter mRNA: Its unique localization and rapid regulation in rat kidney
1996
Alzheimer's Disease
2010 Standout
Major Depressive Disorder
2008 Standout
Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia
1998
Expression of three glutamate transporter subtype mRNAs in human brain regions and peripheral tissues
1996
Interindividual differences in the levels of the glutamate transporters GLAST and GLT, but no clear correlation with Alzheimer's disease
1999
AGING, MILD COGNITIVE IMPAIRMENT, AND ALZHEIMER'S DISEASE
2000
Alzheimer's Disease
2004 Standout
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
1994 Standout
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
1997
Presynaptic and postsynaptic glutamatergic function in Alzheimer's disease
1988
The neuropathology of primary mood disorder
2002
The molecular neurobiology of depression
2008 StandoutNature
Mild cognitive impairment as a diagnostic entity
2004 Standout
Memantine in severe dementia: results of the9M-best study (benefit and efficacy in severly demented patients during treatment with memantine)
1999
Brain angiotensin receptor subtypes in the control of physiological and behavioral responses
1994
Hypertonic Induction of Aquaporin-5 Expression through an ERK-dependent Pathway
2000 StandoutNobel
Effect of Central Cholinergic Stimulation on Regional Cerebral Blood Flow in Alzheimer's Disease
1991
A conformationally constrained competitive inhibitor of the sodium-dependent glutamate transporter in forebrain synaptosomes: l-anti-endo-3,4-methanopyrrolidine dicarboxylate
1994
Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease
1990
Oxidative damage and mitochondrial decay in aging.
1994 Standout
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
2005 Standout
Hippocampal atrophy in recurrent major depression.
1996 Standout
Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors.
1995
Alzheimer's disease
1998 Standout
Epilepsy and Exacerbation of Brain Injury in Mice Lacking the Glutamate Transporter GLT-1
1997 Science
Alzheimer's disease: Glutamate depletion in the hippocampal perforant pathway zone
1987
Transcriptional neoteny in the human brain
2009 StandoutNobel
Cortical magnetic resonance imaging changes in elderly inpatients with major depression
1991
A Century of Alzheimer's Disease
2006 StandoutScience
Changes in period mRNA levels in the brain and division of labor in honey bee colonies
2000
A Family of AMPA-Selective Glutamate Receptors
1990 StandoutScienceNobel
Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI
2004 Standout
Somatostatin content and release measured in cerebral biopsies from demented patients
1987
A new family of neurotransmitter transporters: the high‐affinity glutamate transporters
1993
Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?
1990
Alternative splicing generates functionally distinct N-methyl-D-aspartate receptors.
1992 StandoutNobel
A default mode of brain function
2001 Standout
Spermidine in health and disease
2018 StandoutScience
Neurochemical Correlates of Major Depression in Primary Dementia
1990
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
Alzheimer's Disease Is a Synaptic Failure
2002 StandoutScience
Functional connectivity in the resting brain: A network analysis of the default mode hypothesis
2002 Standout
Conformationally restricted inhibitors of the high affinity -glutamate transporter
1993
Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain.
1992
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
1993 StandoutScience
Recent advances in the phencyclidine model of schizophrenia
1991 Standout
Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices
1987
A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease
1987
Neuropathology of Degenerative Cell Death inCaenorhabditis elegans
1997 StandoutNobel
The Cytolytic P 2Z Receptor for Extracellular ATP Identified as a P 2X Receptor (P2X 7 )
1996 StandoutScience
EAT-4, a Homolog of a Mammalian Sodium-Dependent Inorganic Phosphate Cotransporter, Is Necessary for Glutamatergic Neurotransmission inCaenorhabditis elegans
1999 StandoutNobel
Sodium-dependent glutamate binding in senile dementia
1987
Heteromeric NMDA Receptors: Molecular and Functional Distinction of Subtypes
1992 StandoutScienceNobel
Works of Andrew Procter being referenced
Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy
2007
Characterisation of the Glycine Modulatory Site of the N‐Methyl‐d ‐Aspartate Receptor‐Ionophore Complex in Human Brain
1991
Brain amino acid concentrations and Ca2+-dependent release in intractable depression assessed antemortem
1989
Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms
1992
Topographical distribution of neurochemical changes in Alzheimer's disease
1988
The Effects of Alzheimer's Disease, Other Dementias, and Premortem Course on β‐Amyloid Precursor Protein Messenger RNA in Frontal Cortex
1994
?-Amyloid precursor protein isoforms show correlations with neurones but not with glia of demented subjects
1994
Reduced Glycine Stimulation of [3H]MK‐801 Binding in Alzheimer's Disease
1989
Evidence of Glutamatergic Denervation and Possible Abnormal Metabolism in Alzheimer's Disease
1988
GAMMA-AMINOBUTYRIC ACID CONCENTRATION IN BRAIN TISSUE AT TWO STAGES OF ALZHEIMER'S DISEASE
1988
Possible neurotransmitter basis of behavioral changes in alzheimer's disease
1988
Cortical Pyramidal Neurone Loss May Cause Glutamatergic Hypoactivity and Cognitive Impairment in Alzheimer's Disease: Investigative and Therapeutic Perspectives
1993
Brain Membrane Serine Protease Activity in Human Cortex Compared with Rat: Implication for Alzheimer's Disease
1994
Neurochemical Correlates of Dementia
1996
Terminal coma affects messenger RNA detection in post mortem human temporal cortex
1991
Loss of glycine-dependent radioligand binding to the receptor complex in patients with Alzheimer's disease
1989
Concepts of mild memory impairment in the elderly and their relationship to dementia—a review
1992
Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease
1986
Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life.
1989
Clinical correlations of the neurobiological changes of aging.
1990
Neurotransmitters and Second Messengers in Aging and Alzheimer's Disease
1993